Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

The description adds behavioral details beyond annotations: it pulls specific financial data from SEC EDGAR/XBRL for companies, FAERS data for drugs, handles off-calendar fiscal years, sorts results by primary metric, and returns paired data with citation URIs. Annotations already indicate safe, idempotent behavior.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is well-structured and front-loaded with examples and usage guidance. Every sentence adds value, though it is slightly lengthy. It could be trimmed slightly without losing clarity, but overall it's effective.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the tool's complexity (two entity types, multiple metrics, comparison logic), the description covers all essential aspects: what data is retrieved, how it's sorted, and what output format includes (paired data, citation URIs). No output schema exists, so the description bears the full burden and succeeds.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

The description adds significant meaning beyond the input schema. It explains that 'type="company"' pulls LATEST 10-K revenue, net income, cash, long-term debt and that 'type="drug"' pulls FAERS counts, FDA approvals, active trials. For 'values', it specifies tickers/CIKs for companies and drug names. Schema coverage is 100%, and the description enriches understanding.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool's purpose: side-by-side comparison of 2–5 companies or drugs. It uses specific verbs like 'compare', 'rank', and explicitly mentions use cases. It distinguishes from sequential lookups, making it clear what the tool does and why it's preferred.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly advises to ALWAYS PREFER this tool over sequential single-pack lookups when comparing entities. It provides trigger phrases like 'X vs Y'. However, it does not mention when not to use this tool or suggest alternatives for single entity lookups, but the context is clear.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

B3.4/5.0
Disambiguation2/5

The tool set blends two unrelated domains (TMDB and Pipeworx). Among Pipeworx tools, several overlap heavily (ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, suggest_questions) with vague boundaries, making it hard for an agent to pick the right one. TMDB tools are distinct but the overall mixture creates confusion about which domain a request belongs to.

Naming Consistency3/5

All tools use snake_case, which is consistent. However, naming styles vary widely: TMDB tools use simple noun or verb-first names (movie, search_movie, discover_tv), while Pipeworx tools use longer descriptive phrases with prefixes (ask_pipeworx, polymarket_arbitrage, entity_profile). The pattern is not predictable across the set.

Tool Count2/5

50 tools is excessive for a server named 'Tmdb'. Only about 18 tools are actually TMDB-related; the remaining 32 belong to the Pipeworx ecosystem. This inflates the count and makes the server feel bloated and unfocused, far beyond a well-scoped TMDB server.

Completeness3/5

The TMDB portion is quite complete (search, discover, details, credits, recommendations, trending, genres, configuration). However, the server's overall scope is muddled—it tries to cover two disjoint domains, so no single domain feels fully fleshed out. There are also some missing TMDB features (e.g., upcoming/now playing) that would require extra discovery. The Pipeworx tools cover data broadly but overlap in coverage.